We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600298:SSEAngel Yeast Co., Ltd. Class A Analysis

Data as of 2026-05-29 - not real-time

CN¥36.60

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at ¥36.6, which sits below its 20‑day SMA of ¥36.79, 50‑day SMA of ¥38.85, and 200‑day SMA of ¥40.44, confirming a short‑term bearish bias. Technical signals show a neutral‑to‑slightly‑oversold RSI at 42 and a MACD histogram that has turned positive, hinting at a potential bottoming process. Volume has been on a downtrend, and the price is hovering just above the identified support level of ¥35.21, with resistance near ¥38.70. The beta of 0.15 suggests the share is far less volatile than the broader market, yet 30‑day volatility remains elevated at roughly 18%, indicating intermittent price swings. Despite these technical pressures, the company delivers solid fundamentals: revenue grew 19.5% YoY, operating margin stands at 13.4%, and the dividend yield of 1.5% is supported by a modest 30% payout ratio. The DCF‑derived fair value of ¥48.93 provides a sizeable upside potential of over 30% from current levels. Debt levels are high (debt‑to‑equity ~64%) but are partially offset by a cash balance exceeding ¥2.3 bn, and the consumer‑defensive packaging sector offers resilience amid economic cycles.
Overall, the combination of a clear valuation gap, sustainable dividend, and defensive industry positioning suggests that the stock is fundamentally undervalued, though short‑term price weakness and decreasing volume warrant a cautious approach until price stabilises above support.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price is near the technical support level of ¥35.21
  • Decreasing volume and bearish SMA alignment
  • Potential upside from DCF valuation gap

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong 19.5% revenue growth and solid margins
  • Undervalued relative to DCF fair value of ¥48.93
  • Defensive consumer‑defensive sector supporting stability

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable dividend yield with low payout ratio
  • Long‑term growth prospects in yeast and bio‑ingredients markets
  • Low beta indicating limited market‑wide volatility exposure

Key Metrics & Analysis

Financial Health

Revenue Growth19.50%
Profit Margin9.16%
P/E Ratio19.7
ROE13.06%
ROA4.92%
Debt/Equity63.89
P/B Ratio2.5
Op. Cash FlowCN¥2.4B
Free Cash FlowCN¥-256296704

Technical Analysis

TrendBearish
RSI42.0
SupportCN¥35.21
ResistanceCN¥38.70
MA 20CN¥36.79
MA 50CN¥38.85
MA 200CN¥40.44
MACDBullish
VolumeDecreasing
Fear & Greed Index94.07

Valuation

Fair ValueCN¥48.93
GradeUndervalued
TypeBlend
Dividend Yield1.50%

Risk Assessment

Beta0.15
Volatility17.83%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.